These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
240 related articles for article (PubMed ID: 27444659)
1. Infusion treatments and deep brain stimulation in Parkinson's Disease: The role of nursing. De Rosa A; Tessitore A; Bilo L; Peluso S; De Michele G Geriatr Nurs; 2016; 37(6):434-439. PubMed ID: 27444659 [TBL] [Abstract][Full Text] [Related]
3. Systematic review of apomorphine infusion, levodopa infusion and deep brain stimulation in advanced Parkinson's disease. Clarke CE; Worth P; Grosset D; Stewart D Parkinsonism Relat Disord; 2009 Dec; 15(10):728-41. PubMed ID: 19805000 [TBL] [Abstract][Full Text] [Related]
4. Levodopa enhances synaptic plasticity in the substantia nigra pars reticulata of Parkinson's disease patients. Prescott IA; Dostrovsky JO; Moro E; Hodaie M; Lozano AM; Hutchison WD Brain; 2009 Feb; 132(Pt 2):309-18. PubMed ID: 19050033 [TBL] [Abstract][Full Text] [Related]
5. Motor features and response to oral levodopa in patients with Parkinson's disease under continuous dopaminergic infusion or deep brain stimulation. Elia AE; Dollenz C; Soliveri P; Albanese A Eur J Neurol; 2012 Jan; 19(1):76-83. PubMed ID: 21645174 [TBL] [Abstract][Full Text] [Related]
6. Varying time-course of effects of high frequency stimulation of sub-regions of the globus pallidus in patients with parkinson's disease. Angeli A; Akram H; Zacharia A; Limousin P; Hariz M; Zrinzo L; Foltynie T Parkinsonism Relat Disord; 2015 Jun; 21(6):597-602. PubMed ID: 25842261 [TBL] [Abstract][Full Text] [Related]
7. Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up. Rodriguez-Oroz MC; Obeso JA; Lang AE; Houeto JL; Pollak P; Rehncrona S; Kulisevsky J; Albanese A; Volkmann J; Hariz MI; Quinn NP; Speelman JD; Guridi J; Zamarbide I; Gironell A; Molet J; Pascual-Sedano B; Pidoux B; Bonnet AM; Agid Y; Xie J; Benabid AL; Lozano AM; Saint-Cyr J; Romito L; Contarino MF; Scerrati M; Fraix V; Van Blercom N Brain; 2005 Oct; 128(Pt 10):2240-9. PubMed ID: 15975946 [TBL] [Abstract][Full Text] [Related]
8. When the going gets tough: how to select patients with Parkinson's disease for advanced therapies. Worth PF Pract Neurol; 2013 Jun; 13(3):140-52. PubMed ID: 23487815 [TBL] [Abstract][Full Text] [Related]
9. [Parkinson therapy 2001, especially apomorphine in idiopathic Parkinson syndrome]. Gutknecht C Praxis (Bern 1994); 2001 Jun; 90(23):1024-34. PubMed ID: 11447722 [TBL] [Abstract][Full Text] [Related]
10. Neural substrates and potential treatments for levodopa-induced dyskinesias in Parkinson's disease. Phillips JR; Eissa AM; Hewedi DH; Jahanshahi M; El-Gamal M; Keri S; Moustafa AA Rev Neurosci; 2016 Oct; 27(7):729-738. PubMed ID: 27362959 [TBL] [Abstract][Full Text] [Related]
11. Parkinson's Disease. Reich SG; Savitt JM Med Clin North Am; 2019 Mar; 103(2):337-350. PubMed ID: 30704685 [TBL] [Abstract][Full Text] [Related]
12. Myths and realities of continuous dopaminergic stimulation. Pirtošek Z Psychiatr Danub; 2011 Mar; 23(1):80-3. PubMed ID: 21448103 [TBL] [Abstract][Full Text] [Related]
13. Treatments for Parkinson disease--past achievements and current clinical needs. Poewe W Neurology; 2009 Feb; 72(7 Suppl):S65-73. PubMed ID: 19221317 [TBL] [Abstract][Full Text] [Related]
14. Clinical outcomes using ClearPoint interventional MRI for deep brain stimulation lead placement in Parkinson's disease. Ostrem JL; Ziman N; Galifianakis NB; Starr PA; Luciano MS; Katz M; Racine CA; Martin AJ; Markun LC; Larson PS J Neurosurg; 2016 Apr; 124(4):908-16. PubMed ID: 26495947 [TBL] [Abstract][Full Text] [Related]
15. Subthalamic stimulation in Parkinson's disease: restoring the balance of motivated behaviours. Lhommée E; Klinger H; Thobois S; Schmitt E; Ardouin C; Bichon A; Kistner A; Fraix V; Xie J; Aya Kombo M; Chabardès S; Seigneuret E; Benabid AL; Mertens P; Polo G; Carnicella S; Quesada JL; Bosson JL; Broussolle E; Pollak P; Krack P Brain; 2012 May; 135(Pt 5):1463-77. PubMed ID: 22508959 [TBL] [Abstract][Full Text] [Related]
16. Evidence-based medical review update: pharmacological and surgical treatments of Parkinson's disease: 2001 to 2004. Goetz CG; Poewe W; Rascol O; Sampaio C Mov Disord; 2005 May; 20(5):523-39. PubMed ID: 15818599 [TBL] [Abstract][Full Text] [Related]
17. [Continuous dopaminergic stimulation by Duodopa in advanced Parkinson's disease: Efficacy and safety]. Annic A; Devos D; Seguy D; Dujardin K; Destée A; Defebvre L Rev Neurol (Paris); 2009; 165(8-9):718-27. PubMed ID: 19150100 [TBL] [Abstract][Full Text] [Related]
18. Lack of depotentiation at basal ganglia output neurons in PD patients with levodopa-induced dyskinesia. Prescott IA; Liu LD; Dostrovsky JO; Hodaie M; Lozano AM; Hutchison WD Neurobiol Dis; 2014 Nov; 71():24-33. PubMed ID: 25116960 [TBL] [Abstract][Full Text] [Related]
19. [Treatment possibilities in advanced Parkinson's disease]. Takáts A; Nagy H; Radics P; Tóth A; Tamás G Ideggyogy Sz; 2013 Nov; 66(11-12):365-71. PubMed ID: 24555235 [TBL] [Abstract][Full Text] [Related]